Worldwide barriers to genetic testing for movement disorders

Autor: Gatto, E. M., Walker, R. H., Gonzalez, C., Cesarini, M., Cossu, G., Stephen, C. D., Balint, B., Rodriguez-Violante, M., Jankovic, J., Morgante, F., Jinnah, H. A., Albanese, A., Amorin, I., Bhatia, K., Brandabur, M., Canals, F., Cardoso, F., Cardozo, A., Carvalho, V., Chade, A., Chana, P., Darling, A., Correia Guedes, L., De la Cerda, A., de Koning-Tijssen, M., Della Coletta, M. V., Duquette, A., Espay, A., Etcheverry, J., Ferreira, J., Friedman, J., Fung, V., Ganos, C., Ruiz, P. G., Gershanik, O., Gross, K. B. V., Han-Joon, K., Kaji, R., Kotschet, K., Rosa, A. L. D., Litvan, I., Lubarr, N., Marano, M., Josep Marti, M., Martinez Ramirez, D., Miyasaki, J., Munchau, A., Chesta, D. M., Pal, P., Peralta, M. C., Phielipp, N., Maria Riboldi, G., Oroz, M. C. R., Rodriguez-Porcel, F., Sarva, H., Schoels, L., Stamelou, M., Uribe Roca, C.

Author(s): Gatto, Emilia M; Walker, Ruth H; Gonzalez, Claudio; Cesarini, Martin; Cossu, Giovanni; Stephen, Christopher D; Balint, Bettina; Rodriguez-Violante, Mayela; Jankovic, Joseph; Morgante, Francesca; Jinnah, Hyder A; Rare Movement Disorders Stu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23d0c9a614ddc13771d80d0285fec354
http://hdl.handle.net/11570/3207739

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System

Autor: Thilo vanEimeren, Angelo Antonini, Daniela Berg, Nico Bohnen, Roberto Ceravolo, Alexander Drzezga, Günter U. Höglinger, Makoto Higuchi, Stephane Lehericy, Simon Lewis, Oury Monchi, Peter Nestor, Matej Ondrus, Nicola Pavese, María Cecilia Peralta, Paola Piccini, José Ángel Pineda‐Pardo, Irena Rektorová, María Rodríguez‐Oroz, Axel Rominger, Klaus Seppi, A. Jon Stoessl, Alessandro Tessitore, Stephane Thobois, Valtteri Kaasinen, Gregor Wenning, Hartwig R. Siebner, Antonio P. Strafella, James B. Rowe, MDS Neuroimaging Study Group and the JPND Working Group ASAP‐SynTau

Publikováno v: Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 11, Iss 1, Pp 301-309 (2019)
Alzheimer's & dementia / Diagnosis, assessment & disease monitoring 11(1), 301-309 (2019). doi:10.1016/j.dadm.2019.01.011
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
van Eimeren, Thilo; Antonini, Angelo; Berg, Daniela; Bohnen, Nico; Ceravolo, Roberto; Drzezga, Alexander; Höglinger, Günter U.; Higuchi, Makoto; Lehericy, Stephane; Lewis, Simon; Monchi, Oury; Nestor, Peter; Ondrus, Matej; Pavese, Nicola; Peralta, María Cecilia; Piccini, Paola; Pineda-Pardo, José Ángel; Rektorová, Irena; Rodríguez-Oroz, María; Rominger, Axel; ... (2019). Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System. Alzheimer's & dementia: Diagnosis, Assessment & Disease Monitorin, 11, pp. 301-309. Elsevier 10.1016/j.dadm.2019.01.011

Introduction Therapeutic strategies targeting protein aggregations are ready for clinical trials in atypical parkinsonian disorders. Therefore, there is an urgent need for neuroimaging biomarkers to help with the early detection of neurodegenerative

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c0a0c06eae74a45e802bf982907e334
https://mediatum.ub.tum.de/doc/1543982/document.pdf